Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-18

Clinical Trial Update: Topical Application of Latanoprost in Diabetic Retinopathy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated topical latanoprost for diabetic retinopathy and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)

Snippet

Sponsor: University of Aarhus | Conditions: Diabetic Retinopathy | Phase 4 | Status: COMPLETED